Hereditary cancer research publications

Publications

Our mission is to improve the lives of individuals and families facing hereditary cancer.

Stay up to date on research and information

About Us > Publications

Diversity and Inclusion Our Mission and Impact Our Programs News & Media Center FORCE Staff Board of Directors & Advisory Board Financials Retail Partners Our Supporters Our Partners Publications Contact Us Spirit of Empowerment

FORCE contributes to and collaborates with investigators who build on scientific knowledge through publication of research findings. Read the below list of publications and presentations that involved FORCE effort and staff.

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

I Bedrosian, M Somerfield, M Isabel Achatz, J Boughey, G Curigliano, Sue Friedman, W Kohlmann, A Kurian, C Laronga, F Lynce, B Norquist, et. al. J. of Clin. Onc., Jan 4, 2024.

Needs of oncology nurse navigators serving young or metastatic breast cancer patients

Kelly N. Owens PhD; Marleah Dean PhD; Elizabeth Bourquardez Clark MPH; Piri Welcsh PhD; Diane Rose; Erica S. Kuhn MPH; Jessica Conaty MPH; Robin H. Pugh Yi; Susan J. Friedman, DVM. Presented at the San Antonio Breast Cancer Symposium® December 5-9, 2023.

Experiences of genetic counselors in referring young and metastatic breast cancer patients to support services: A needs assessment

Clark E; Bonini K; Pugh Yi R; Kuhn E; Klemp J; Rose D; Owens K N; Welcsh P; Conaty J; Duquette D; Friedman S J; Dean M. Patient Education and Counseling Volume 116, November 2023.

Advancing Progress in Cancer Prevention and Risk Reduction: Proceedings of a National Academies of Sciences, Engineering, and Medicine Workshop

The National Academies Press. 2023.

People with metastatic breast cancer face barriers to finding information and support

Pugh Yi R; Welcsh P; Owens K; Rose D; Dearfield C; Kuhn E; Friedman S. Presented at the San Antonio Breast Cancer Symposium - December 9, 2022.

Identification and management of individuals at risk for hereditary cancer in the Medicare population and beyond

Lisa Schlager, Kelly Owens, PhD, Piri Welcsh, PhD, Presented at the International Society of Nurses in Genetics (ISONG) World Congress, November 2022.

Experiences of genetic counselors in referring young and metastatic breast cancer patients to supportive services: A needs assessment

Boninil K, Clark E, Pugh Yi R, Kuhn E, Klemp J, Rose D, Owens K, Welsh P, Duquette D, Friedman S, Dean M, presented at the NSGC conference, Nashville, 11/16/2022

Results of training on digital health literacy for genetic counseling training programs

Pugh Yi R, Dean M, Welcsh P, Owens K, Rose D, Dearfield C, Kuhn E, Clark E, Friedman S. Presented at the American Public Health Association annual meeting, November 6, 2022.

Caregiving in hereditary cancer: Caregivers’ resource and support needs

Mountcastle, L., Friedman, S., & Koehly, L.M. (2022, November 16-20). [Virtual Poster Presentation]. To be presented at the National Society of Genetic Counselors 41st Annual Conference, Nashville, TN.

An evidence-based practice guideline of the National Society of Genetic Counselors for telehealth genetic counseling

Green, S., Hartzfeld, D., Terry, A. B., Fissell, K., Friedman, S., Paolino, N., Principe, K., Sandbach, J., Trzupek, K., Winheld, S., & Malinowski, J. (2022). Journal of Genetic Counseling. August, 2022.

Quality of life results from OlympiA phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations...

Ganz P; Bandos H, Spanic T, Friedman S, Müller V; et. al. Cancer Res (2022) 82 (4_Supplement): GS4-09. February, 2022.

Medicaid expansions: Probing Medicaid’s filling of the cancer genetic testing and screening space

Modell, S.M.; Schlager, L.; Allen, C.G.; Marcus, G. Healthcare 2022, 10, 1066.

Using consistent terms in precision medicine to eliminate patient confusion

Martin N, Friedman S, Saxton C, Yarden R, Lindsey S, Kuhn E, Guglielmino J, et. al. Journal of Clinical Oncology 2020 38:15_suppl, e24164-e24164

Utilization, timing, and outcomes of BRCA genetic testing among women with newly diagnosed breast cancer from a national commercially insured population: The ABOARD study

Armstrong J, Lynch K, PhD2; Virgo K, Schwartz M, Friedman S, Dean M, Sutphen R, et. al. JCO Oncology Practice (ascopubs.org). JCO Oncology Practice 2021 17:2, e226-e235

BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study

Filipa Lynce, Ilana Schlam, Xue Geng, Beth N Peshkin, Sue Friedman, Julie Dutil, Claudine Isaacs, Kristi D Graves, et. al. J Genet Couns. 2021; 30: 383– 393.

The impact of germline testing for hereditary cancer postdiagnosis

Owens K, Schlager L, Welcsh PL. Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287.

Results of a pilot test of effects of an online resource on lay audience understanding of media reports on breast cancer research

Yi, R. H. P., Rezende, L., Dearfield, C. T., Welcsh, P., & Friedman, S. (2019). Health Education Journal, 78(5), 607–617.

Effects of online resource to support laypersons’ understanding of media reports on breast cancer research

Pugh-Yi RH, Rezende, Dearfield CT, Owens KN, Welcsh PL, Friedman SJ. Dec. 8, 2018. San Antonio Breast Cancer Symposium Abstract P6-14-08.

Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: The ABOUT study

Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Sutphen R. , et. al. JAMA Oncol. 2015 Dec;1(9):1251-60.

Development, Implementation, and Evaluation of the eXamining Relevance of Articles to Young Survivors (XRAYS) program to summarize recent research findings for young breast cancer survivors...

Pugh-Yi R, PhD, Rezende L, Kramer K, Schlager L, Huynh J, Friedman S. Presentation at the American Public Health Association National Meeting, November 2015.

XRAYS (eXamining Relevance of Articles to Young Survivors) program survey of information needs and media use by young breast cancer survivors and young women at high-risk for breast cancer

Yi RHP, Rezende LF, Huynh J, Kramer K, Cranmer M, Schlager L, Dearfield CT, Friedman SJ. Health Commun. 2018 Dec;33(12):1525-1530. doi: 10.1080/10410236.2017.1372051. Epub 2017 Sep 28. PMID: 28956616.

XRAYS (eXamining Relevance of Articles to Young Survivors) program survey of information needs and media use by young breast cancer survivors and young women at high risk for breast cancer

Rezende L, Huynh J, Kramer K, Cranmer M, Schlager L, Pugh-Yi R, Friedman S. Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12.

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH. Gynecol Oncol. 2014 May;133(2):283-6. doi: 10.1016/j.ygyno.2014.02.030. Epub 2014 Feb 28. PMID: 24582866; PMCID: PMC4035022.

About Force